Cargando…

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease

BACKGROUND: Chronic kidney disease (CKD) leads to low serum concentrations of vitamin D metabolites. Thus, hypovitaminosis D associated with CKD might contribute to disease progression via increased concentration of renin angiotensin aldosterone system (RAAS) mediators. OBJECTIVES: To evaluate wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miller, Matthew, Quimby, Jessica, Langston, Catherine, Ames, Marisa, Parker, Valerie J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	SMALL ANIMAL
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511075/ https://www.ncbi.nlm.nih.gov/pubmed/35962709 http://dx.doi.org/10.1111/jvim.16499

Ejemplares similares

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
por: Ames, Marisa K., et al.
Publicado: (2022)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

Effects of calcifediol supplementation on markers of chronic kidney disease‐mineral and bone disorder in dogs with chronic kidney disease
por: Parker, Valerie J., et al.
Publicado: (2020)

The Renin‐Angiotensin‐Aldosterone System in Greyhounds and Non‐Greyhound Dogs
por: Martinez, J., et al.
Publicado: (2017)

Changes in renin‐angiotensin‐aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs
por: Cheng, Chieh‐Jen, et al.
Publicado: (2022)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Effect of spironolactone and benazepril on furosemide‐induced diuresis and renin‐angiotensin‐aldosterone system activation in normal dogs
por: Adin, Darcy, et al.
Publicado: (2021)

Circulating renin‐angiotensin‐aldosterone system activity in cats with systemic hypertension or cardiomyopathy
por: Ward, Jessica L., et al.
Publicado: (2022)

Influence of sex on renin‐angiotensin‐aldosterone system metabolites and enzymes in Doberman Pinschers
por: Adin, Darcy B., et al.
Publicado: (2022)

Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals
por: Sakamoto, Yumi, et al.
Publicado: (2019)

The classical and alternative circulating renin‐angiotensin system in normal dogs and dogs with stage B1 and B2 myxomatous mitral valve disease
por: Hammond, Hillary H., et al.
Publicado: (2023)

Role of electrolyte concentrations and renin‐angiotensin‐aldosterone activation in the staging of canine heart disease
por: Adin, Darcy, et al.
Publicado: (2019)

Suspected primary hyperreninism in a cat with malignant renal sarcoma and global renin‐angiotensin‐aldosterone system upregulation
por: Evans, Jeremy, et al.
Publicado: (2021)

Factors associated with survival in dogs with chronic kidney disease
por: Rudinsky, Adam J., et al.
Publicado: (2018)

Short‐term efficacy of epidural pain management in dogs undergoing cystoscopy
por: Rayhel, Laura H., et al.
Publicado: (2021)

Characterization of the intrarenal renin‐angiotensin system in cats with naturally occurring chronic kidney disease
por: Lourenço, Bianca N., et al.
Publicado: (2022)

Clinicopathologic characteristics, pathology, and prognosis of 77 dogs with focal segmental glomerulosclerosis
por: Lorbach, Sarah K., et al.
Publicado: (2020)

Validation of a Clinical Scoring System for Outcome Prediction in Dogs with Acute Kidney Injury Managed by Hemodialysis
por: Segev, G., et al.
Publicado: (2016)

Comparison of Single, Averaged, and Pooled Urine Protein:Creatinine Ratios in Proteinuric Dogs Undergoing Medical Treatment
por: Shropshire, S., et al.
Publicado: (2017)

Light chain myeloma and detection of free light chains in serum and urine of dogs and cats
por: Harris, Robert Adam, et al.
Publicado: (2021)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2020)

Hypothermia in Uremic Dogs and Cats
por: Kabatchnick, E., et al.
Publicado: (2016)

Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease
por: Paschall, Rene E., et al.
Publicado: (2023)

Plasma and tissue angiotensin‐converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2019)

Effect of Breed on Plasma Endothelin‐1 Concentration, Plasma Renin Activity, and Serum Cortisol Concentration in Healthy Dogs
por: Höglund, K., et al.
Publicado: (2016)

Changes in diet and supplement use in dogs with cancer
por: Kramer, Matthew L., et al.
Publicado: (2023)

The fecal microbiome and serum concentrations of indoxyl sulfate and p‐cresol sulfate in cats with chronic kidney disease
por: Summers, Stacie C., et al.
Publicado: (2018)

Effect of telmisartan, angiotensin‐converting enzyme inhibition, or both, on proteinuria and blood pressure in dogs
por: Fowler, Brittany L., et al.
Publicado: (2021)

Iron Status of Cats with Chronic Kidney Disease
por: Gest, J., et al.
Publicado: (2015)

Association between vitamin D metabolites, vitamin D binding protein, and proteinuria in dogs
por: Miller, Matthew S., et al.
Publicado: (2020)

Blood Transfusions in Dogs and Cats Receiving Hemodialysis: 230 Cases (June 1997–September 2012)
por: Langston, C., et al.
Publicado: (2017)

Retrospective evaluation of a dose‐dependent effect of angiotensin‐converting enzyme inhibitors on long‐term outcome in dogs with cardiac disease
por: Ward, Jessica L., et al.
Publicado: (2021)

Fibroblast Growth Factor‐23 Concentration in Dogs with Chronic Kidney Disease
por: Harjes, L.M., et al.
Publicado: (2017)

Amino acid status in dogs with protein‐losing nephropathy
por: Parker, Valerie J., et al.
Publicado: (2019)

Oral Cobalamin Supplementation in Dogs with Chronic Enteropathies and Hypocobalaminemia
por: Toresson, L., et al.
Publicado: (2016)

Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors
por: Fulton, Emily A., et al.
Publicado: (2023)

Intra‐arterial renal infusion of autologous mesenchymal stem cells for treatment of chronic kidney disease in cats: Phase I clinical trial
por: Thomson, Abigail L., et al.
Publicado: (2019)

Serum uromodulin in dogs with chronic kidney disease
por: Seo, Dansong, et al.
Publicado: (2022)

Urinary F(2)‐Isoprostanes in Cats with International Renal Interest Society Stage 1–4 Chronic Kidney Disease
por: Whitehouse, W., et al.
Publicado: (2017)

Preliminary evaluation of fecal fatty acid concentrations in cats with chronic kidney disease and correlation with indoxyl sulfate and p‐cresol sulfate
por: Summers, Stacie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_niggo543rsnmf274mbsg8naiqe